Compounding Pharmaceutical Companies Webinar 
pharmaphorum
MARCH 19, 2021
The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this. How engagement with HCPs will evolve in the future.
Viseven
AUGUST 15, 2024
In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceutical companies, creating a unique opportunity to build trust with patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 23, 2021
A recent pharmaphorum webinar on digital transformation , held in association with P360, explored how COVID has fast-tracked pharma’s long-held ambitions to make wider use of digital technology and streamline its communications with HCPs. Physician access issues coupled with message delivery disconnects only compounded the problem.
Pharmaceutical Technology
MARCH 22, 2023
Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceutical companies. This on-demand webinar discusses the importance of a patient-appropriate BL & GF profile. Regulators are also paying close attention to the risks.
Pharmaceutical Technology
DECEMBER 15, 2022
From alcohols to quaternary ammonium compounds, each type of agent has a unique mode of action, with varying degrees of efficacy. Antimicrobial agents can be used both as active pharmaceutical ingredient (API) and as excipients. There are many other aspects to take into consideration. Is Benzalkonium Chloride a good choice?
Expert insights. Personalized for you.
141 
Let's personalize your content